By browsing our site you agree to our use of cookies. You will only see this message once. Find out more

This Framework Agreement is for the supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG). The Goods have been split into four (4) categories, each of which is identified as a ‘Lot’. The Lots are as follows: Lot 1 - ...

Contract notice

Supplies

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
United Kingdom
Contact person: Hazel Johnstone
Telephone: +44 1698794561
E-mail:
NUTS code: UKM

Internet address(es):

Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/

Address of the buyer profile: http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

I.2)Joint procurement
The contract is awarded by a central purchasing body
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.htmlh
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG).

Reference number: NP32617
II.1.2)Main CPV code
33600000
II.1.3)Type of contract
Supplies
II.1.4)Short description:

This Framework Agreement is for the supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG).

The Goods have been split into four (4) categories, each of which is identified as a ‘Lot’.

The Lots are as follows:

Lot 1 - Human Normal Intravenous Immunoglobulin 5 %

Lot 2 - Human Normal Intravenous Immunoglobulin 10 %

Lot 3 - Human Normal Intravenous Immunoglobulin for Subcutaneous Use

Lot 4 - Subcutaneous Immunoglobulin with Hyaluronidase

All deliveries under the framework agreement will be to one central location, namely ‘The Scottish National Blood Transfusion Service’ (SNBTS), Edinburgh.

II.1.5)Estimated total value
Value excluding VAT: 78 000 000.00 GBP
II.1.6)Information about lots
This contract is divided into lots: yes
Tenders may be submitted for all lots
II.2)Description
II.2.1)Title:

Supply of Human Normal Intravenous Immunoglobulin 5 %

Lot No: 1
II.2.2)Additional CPV code(s)
33141520
33651520
II.2.3)Place of performance
NUTS code: UKM
Main site or place of performance:

Scottish National Blood Transfusion Service (SNBTS), Edinburgh.

II.2.4)Description of the procurement:

Supply of Human Normal Intravenous Immunoglobulin 5 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage.

This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot.

II.2.5)Award criteria
Criteria below
Quality criterion - Name: Range of Vial Sizes / Weighting: 10
Quality criterion - Name: Storage Conditions / Weighting: 5
Price - Weighting: 85
II.2.6)Estimated value
Value excluding VAT: 4 450 000.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: yes
Description of renewals:

The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.

II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Supply of Human Normal Intravenous Immunoglobulin 10 %

Lot No: 2
II.2.2)Additional CPV code(s)
33141520
33651520
II.2.3)Place of performance
NUTS code: UKM
Main site or place of performance:

Scottish National Blood Transfusion Service (SNBTS), Edinburgh.

II.2.4)Description of the procurement:

Supply of Human Normal Intravenous Immunoglobulin 10 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage.

This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot.

II.2.5)Award criteria
Criteria below
Quality criterion - Name: Range of Vial Sizes / Weighting: 10
Quality criterion - Name: Storage Conditions / Weighting: 5
Price - Weighting: 85
II.2.6)Estimated value
Value excluding VAT: 60 000 000.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: yes
Description of renewals:

The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.

II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use

Lot No: 3
II.2.2)Additional CPV code(s)
33141520
33651520
II.2.3)Place of performance
NUTS code: UKM
Main site or place of performance:

Scottish National Blood Transfusion Service (SNBTS), Edinburgh.

II.2.4)Description of the procurement:

Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use across various vial sizes including current Primary Immune Deficiencies (PID) usage.

This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot.

II.2.5)Award criteria
Criteria below
Quality criterion - Name: Range of Vial Sizes / Weighting: 10
Quality criterion - Name: Storage Conditions / Weighting: 5
Price - Weighting: 85
II.2.6)Estimated value
Value excluding VAT: 13 550 000.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: yes
Description of renewals:

The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.

II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Supply of Subcutaneous Immunoglobulin with Hyaluronidase

Lot No: 4
II.2.2)Additional CPV code(s)
33141520
33651520
II.2.3)Place of performance
NUTS code: UKM
Main site or place of performance:

Scottish National Blood Transfusion Service (SNBTS), Edinburgh.

II.2.4)Description of the procurement:

Supply of Subcutaneous Immunoglobulin with Hyaluronidase. The Authority intends awarding all presentations within this Lot to a single supplier.

II.2.5)Award criteria
Criteria below
Quality criterion - Name: Range of Vial Sizes / Weighting: 10
Quality criterion - Name: Storage Conditions / Weighting: 5
Price - Weighting: 85
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: yes
Description of renewals:

The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.

II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

III.1.2)Economic and financial standing
III.1.3)Technical and professional ability
List and brief description of selection criteria:

(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender.

(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

Minimum level(s) of standards possibly required:

(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.

(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.

III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
Envisaged maximum number of participants to the framework agreement: 6
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 27/03/2017
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
English
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
IV.2.7)Conditions for opening of tenders
Date: 27/03/2017
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.2)Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3)Additional information:

The estimated values referred to in this notice cover the initial twenty-four (24) months duration of the Framework Agreement and the full twenty-four (24) months extension options.

The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 7531. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

The Contracting Authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason:

It is not envisaged that sub-contractors will be utilised in delivery of this framework agreement.

The Contracting Authority does not intend to include any community benefit requirements in this contract for the following reason:

No Community Benefits will be deliverable through the award of this framework agreement.

(SC Ref:479229).

VI.4)Procedures for review
VI.4.1)Review body
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
United Kingdom
Telephone: +44 1698794410

Internet address:http://www.nhsscotlandprocurement.scot.nhs.uk/

VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice:
23/02/2017